Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | n/a | (305.96) | (240.58)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 7.17 | (386.31) | (313.72)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 26.64 | (452.87) | (342.90)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Viking Therapeutics soars 120% following positiv... | 18-Sep-2018 | ShareCast |
Currency | US Dollars |
Share Price | $ 25.27 |
Change Today | $ -0.21 |
% Change | -0.82 % |
52 Week High | $78.03 |
52 Week Low | $21.28 |
Volume | 88,820 |
Shares Issued | 72.03m |
Market Cap | $1,820.14m |
RiskGrade | 326 |
Strong Buy | 7 |
Buy | 9 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 18 |
Time | Volume / Share Price |
15:59 | 200 @ $25.27 |
15:59 | 200 @ $25.27 |
15:59 | 195 @ $25.27 |
15:59 | 100 @ $25.26 |
15:59 | 126 @ $25.25 |
You are here: research